Skip to content
Medical Health Aged Care

RACGP urges new Medicare item to achieve cost savings and improve patient care access

Royal Australian College of GPs 3 mins read

The Royal Australian College of General Practitioners (RACGP) is calling on the federal Government to introduce a new Medicare item to increase patient access to treatment for iron deficiency anaemia and achieve massive cost savings.

It comes following the College’s submission to the Medical Benefits Schedule (MBS) Review Advisory Committee’s MBS Continuous Review.

RACGP President Dr Nicole Higgins said that a new Medicare item would lead to faster treatment and significant government savings.

“We estimate that supporting the delivery of iron infusions in GP clinics through a new Medicare item could deliver cost savings to government of as much as $123 million per year. It would also reduce out of pocket costs for patients and keep people out of hospital,” she said.

In 2021-22 alone, more than 60,000 patients were admitted to hospital for severe iron deficiency anaemia and received same day treatment. Many of these patients could have received their infusions in general practice instead. Advances in technology mean that this is an absolute no-brainer. The Government should act to save money and improve access for patients without delay. The new item should be combined with dynamic public health messaging educating patients across Australia about the causes and symptoms of iron deficiency and nutritional information about how to boost iron levels in our diet.

“This is a problem that needs fixing right away. Iron deficiencies are the most common nutritional deficiency in Australia and remain stubbornly underdiagnosed. Patients with sufficiently low iron for a long period can develop anaemia and may need to be hospitalised. Despite the seriousness of this deficiency, access to iron infusions can prove problematic. That is because historically iron infusions were administered in hospitals. The rationale behind this was safety concerns relating to now obsolete formulations of the iron being used in the infusions. These days, we have new formulations that can be safely delivered by a GP in their clinic.

“So, the technology is available, but what is holding us back is the fact that there are no Medicare items subsidising iron infusions in general practice. As a result, many practices charge over $200 to administer them and whilst the practice can bill a standard consultation item, hence lowering the patient’s out-of-pocket costs by $41.10 or $80.10 depending on concessions, they cannot bill a longer item as nurse time cannot be included when billing these items. The monitoring time also impacts access to the consultation room for the GP to be able to see other patients, reducing overall patient load.

“Out-of-pocket patient fees of well over $100 are out of the reach for many people, particularly at a time of high cost of living pressures. So, instead patients end up on waiting lists to receive the iron infusion in a public hospital or outpatient clinic, if one is available. Their care is delayed by months, and in the meantime their condition can significantly deteriorate.

“These delays can cause patients to become severely anaemic and, as a result, they may then require hospitalisation. Keep in mind that hospital presentations of even minor or medium complexity cost the taxpayer $1,118.50 to $2,113.50 per presentation. In addition to government savings, it would mean more patients accessing care faster and more conveniently from a GP they know and trust, furthering enhancing continuity of care.

“The solution is right in front of us – a new Medicare item subsidising iron infusions in general practice so that more patients can get the treatment they need, when they need it.”


RACGP spokespeople are available for interview.

About us:

About the RACGP

The Royal Australian College of General Practitioners (RACGP) was established in 1958 and is Australia’s peak general practice representative organisation.

The RACGP has more than 41,000 members working in or towards a career in general practice, more than 9,500 of them live and work in rural and remote areas of the country. Nine in every 10 GPs are with the RACGP.

Visit To unsubscribe from RACGP media releases, click here.

Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer


Email: (we will respond promptly to all media inquiries).

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • CharitiesAidWelfare, Medical Health Aged Care
  • 19/04/2024
  • 06:00
Leukaemia Foundation

Hon. Anna Bligh AC Joins Leukaemia Foundation as National Ambassador: A Decade in Remission from Blood Cancer

The Leukaemia Foundation today unveiled a powerful addition to its team of Ambassadors, the Honourable Anna Bligh AC. As the former Premier of Queensland…

  • Contains:
  • Community, Medical Health Aged Care
  • 18/04/2024
  • 22:00
Hepatitis NSW

Hepatitis NSW supports World Liver Day with launch of new website highlighting liver health

Hepatitis NSW has joined the worldwide movement to celebrate World Liver Day on Friday, 19 April 2024. World Liver Day aims to raise awareness about the importance of liver health. The liver is one of the most important organs in your body and is also one of the largest. The liver is an essential organ that performs over 500 functions, in doing so it supports the stomach, the heart and the blood. Specifically, it cleans blood, breaks down food, stores energy and vitamins, sends energy and vitamins to the parts of the body where it is all needed, clots the…

  • CharitiesAidWelfare, Medical Health Aged Care
  • 18/04/2024
  • 15:08
Leukaemia Foundation

The biggest challenge of cancer patients that nobody talks about… How the Leukaemia Foundation is combatting cancer related fatigue

It’s the number one challenge of people with cancer in Australia[i], yet ‘cancer related fatigue’ is the often-unspoken side effect that drains and debilitates thousands of Australians every day. With approximately one in two cancer patients reportedly experiencing moderate to severe fatigue during treatment[ii], and for many in the years following, the Leukaemia Foundation believes the prevalence of cancer related fatigue could be much higher. According to CEO, Chris Tanti, with the incidence of blood cancer continuing to soar (by 47% in the last decade[iii]), this means at least 70,000 Australians living with the disease are facing a daily battle…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.